Table 2

Problems with malaria care quality among febrile under five children in 25 LMICs by treatment cascade

CountryNot blood tested*Not treated with any drug†Treated with only one malarial drug†Receipt of treatment after 24 hours‡
N%N%N%N%
Tanzania (n=1413)103573%61444%78156%47661%
Nigeria (n=2213)180782%146569%62329%42563%
Mozambique (n=1018)49649%56356%43443%435100%
Mali (n=1655)136382%119375%36623%28371%
Cambodia (n=1062)98593%1060100%10%1100%
Burkina Faso (n=2200)136762%124057%90341%60965%
Madagascar (n=899)72681%81891%799%6479%
Togo (n=708)45364%47668%22432%14966%
Zimbabwe (n=486)40183%47798%61%450%
Angola (n=912)51657%62770%26430%21381%
Namibia (n=433)33277%41796%133%1381%
Malawi (n=1082)55451%75471%31029%17456%
Cameroon (n=1204)90176%28324%19869%
Ethiopia (n=624)53286%8313%85100%
Uganda (n=1329)82262%118489%1088%8156%
Rwanda (n=659)40061%61994%376%2978%
Gambia (n=371)22160%35496%144%857%
Ghana (n=830)41850%49860%17221%19760%
Kenya (n=1146)65457%111497%252%1858%
Burundi (n=1068)51448%93087%12712%6950%
Swaziland (n=586)58299%41%4100%
Senegal (n=2926)269092%1676%18281%
Zambia (n=2411)99641%229995%1074%8778%
Sierra Leone (n=1495)63843%140594%685%5464%
Liberia (n=944)29832%81387%10812%9172%
Total (n=29 674)14 99623 62553073949
Mean62%82%17%72%
  • There is no available information on blood testing in Cameroon, Ethiopia, Senegal and Swaziland. All data were analysed using survey weights.

  • *Among those with fever reported in the last 2 weeks.

  • †Among those with fever reported in the last 2 weeks and had a treatment encounter.

  • ‡Among those with fever reported in the last 2 weeks and were treated with any malarial drug.

  • LMICs, low-income and middle-income countries.